Skip to main content

ADVERTISEMENT

combination therapies

Research in Review
08/12/2016
JCP Editors
East Asian patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and epidermal growth factor receptor mutations may benefit from treatment with pemetrexed plus gefitinib, results from a phase II...
East Asian patients with advanced nonsquamous non-small cell lung cancer (NSCLC) and epidermal growth factor receptor mutations may benefit from treatment with pemetrexed plus gefitinib, results from a phase II...
East...
08/12/2016
Journal of Clinical Pathways